VivoSeq
Other

Pain, Postoperative

5

Pipeline Programs

8

Active Trials

2

Companies Involved

Pain, Postoperative is an early-stage landscape with 5 programs across 2 companies. The most active players are Milestone Pharmaceuticals Inc., TLC Biopharmaceuticals, Inc.. 1 therapy is approved.

Pipeline Metrics

Competitive Density

34/100

Pipeline Velocity

22/100

Mech. Concentration

100/100

Completion Rate

0/100

Attrition Rate

10/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

Trial Status

10

clinical trials

Not yet recruiting3 · 30%
Recruiting3 · 30%
Enrolling by invitation2 · 20%
Terminated1 · 10%
Suspended1 · 10%

Trial Activity

10 trials

Dosing of Methadone for Spine Surgery
Terminated·UUniversity of Florida·Phase 2·NCT03605901·21 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)